HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 511 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,200,950 | -32.7% | 79,737 | -28.6% | 0.04% | -36.1% |
| Q1 2023 | $12,193,121 | +599.3% | 111,720 | +629.1% | 0.06% | +510.0% |
| Q4 2022 | $1,743,644 | -92.4% | 15,322 | -95.9% | 0.01% | -91.9% |
| Q3 2022 | $22,904,000 | +318.0% | 370,068 | +438.7% | 0.12% | +342.9% |
| Q2 2022 | $5,480,000 | -46.7% | 68,701 | -29.7% | 0.03% | -51.7% |
| Q1 2022 | $10,278,000 | +297.9% | 97,695 | +314.3% | 0.06% | +241.2% |
| Q3 2021 | $2,583,000 | -54.1% | 23,578 | -60.8% | 0.02% | -56.4% |
| Q2 2021 | $5,632,000 | -54.8% | 60,141 | -64.7% | 0.04% | -62.9% |
| Q4 2020 | $12,461,000 | -49.6% | 170,355 | -46.4% | 0.10% | -49.0% |
| Q3 2020 | $24,708,000 | -2.3% | 318,080 | -30.1% | 0.21% | -28.7% |
| Q2 2020 | $25,278,000 | +271.6% | 454,808 | +98.1% | 0.29% | +48.2% |
| Q1 2020 | $6,802,000 | -0.6% | 229,641 | +21.5% | 0.20% | +46.6% |
| Q4 2019 | $6,841,000 | +386.9% | 188,989 | +266.3% | 0.13% | +454.2% |
| Q3 2019 | $1,405,000 | – | 51,596 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |